BNN — BRAIN Biotech AG Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for BRAIN Biotech AG, fiscal year end - September 30th, EUR millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	19	24.6	8.8	5.41	27.3
Net Total Accounts Receivable
Net Total Receivables	6.57	6.95	11.3	9.83	8.24
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	33.1	39.1	30.4	25.5	45.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	24.5	24.3	28.7	28.7	27.9
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	72.2	77.7	78	70.9	88.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12.4	11.3	21.4	17.5	25
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	51.4	39	48.4	49.2	76.1
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	20.8	38.8	29.6	21.8	12.6
Total Liabilities & Shareholders' Equity	72.2	77.7	78	70.9	88.7
Total Common Shares Outstanding